Evommune will leverage Accutar's AI-empowered drug discovery system for therapies focusing on persistent inflammatory health conditions PALO ALTO, Calif. and...
discovery
Perform by Adler et al.2 describes a 2-phase in vitro procedure for efficient genome enhancing of phages involving the wide-spectrum...